$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Medication recommendations for common lung cancer targeted drugs and a list of drugs that affect the efficacy of lung cancer targeted drugs
2025-10-19 11:44:20
Check Details
The emergence of rubiktidine has given patients with lung cancer a new option for second-line treatment!
2025-10-19 11:44:20
Check Details
Where can I buy rubicidine? How much does a box of rubicidine cost in 2021?
2025-10-19 11:44:20
Check Details
Is bimetinib suitable for patients with lung cancer?
2025-10-19 11:44:20
Check Details
How effective is rubicitin in treating lung cancer? What should I pay attention to during treatment with rubicutidine?
2025-10-19 11:44:20
Check Details
After reading this, you will understand the amazing effects and efficacy of rubictidine!
2025-10-19 11:44:20
Check Details
Chinese medication instructions for Opdivo nivolumab
2025-10-19 11:44:20
Check Details
Tagrisso (osimertinib) global drug price in 2021, which one is cheaper
2025-10-19 11:44:20
Check Details
When is the best time to take Tagrisso? How should we deal with Tagrisso drug resistance?
2025-10-19 11:44:20
Check Details
Learn about the lung cancer targeted drug Tagrisso and Osimertinib in three minutes
2025-10-19 11:44:20
Check Details
What is the effect of Tagrisso, the miracle drug for lung cancer? What is the price of Tagrisso's first-line treatment for lung cancer after it is included in medical insurance?
2025-10-19 11:44:20
Check Details
How long can people with lung cancer live after taking Iressa? How long can people live after Iressa treats advanced lung cancer?
2025-10-19 11:44:20
Check Details
1
2
...
3941
3942
3943
3944
3945
3946
3947
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
2
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
3
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
4
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
5
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
6
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
7
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
8
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
9
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
10
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments
11
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
12
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum